Skip to content

Exploring the optimal PPG range for cirrhosis patients with EGVB after TIPS

Exploring the optimal PPG range for cirrhosis patients with EGVB after TIPS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083897
Enrollment
Unknown
Registered
2024-05-07
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhosis

Interventions

TIPS treatment group:transjugular intrahepatic portosystemic shunt, TIPS

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-75 years old; patients with liver cirrhosis diagnosed based on clinical manifestations, laboratory and imaging examinations; patients who have experienced EGVB in the past and plan to undergo elective TIPS surgery for secondary prevention of EGVB.

Exclusion criteria

Exclusion criteria: Previous TIPS, surgical shunt, or other abdominal surgery; previous recurrent episodes of overt hepatic encephalopathy (more than or equal to 2 times), hepatic myelopathy, or other neuropsychiatric diseases; portal vein cavernous degeneration; liver function Child-Pugh score greater than 13 score or MELD score greater than 30 points; insufficiency of major organs such as heart, lung, kidney, brain, etc.; liver cancer and other malignant tumors other than Milan criteria; pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Clinical events related to cirrhosis (rebleeding, worsening of ascites, overt hepatic encephalopathy, infection, acute-on-chronic liver failure, liver transplantation and death);

Secondary

MeasureTime frame
Laboratory tests (blood routine, coagulation function, blood biochemistry, blood ammonia);;

Countries

China

Contacts

Public ContactHao Wu

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University

hxxhxh@163.com+86 189 8060 1287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026